Combs, Stephanie 1976-
Combs, S. E.
Combs, S. E. (Stephanie Elisabeth)
Stephanie E. Combs
VIAF ID: 64948969 ( Personal )
Permalink: http://viaf.org/viaf/64948969
Preferred Forms
- 100 1 _ ‡a Combs, S. E.
- 100 1 _ ‡a Combs, S. E. ‡q (Stephanie Elisabeth)
- 100 1 _ ‡a Combs, Stephanie ‡d 1976-
- 100 1 _ ‡a Combs, Stephanie ‡d 1976-
- 100 0 _ ‡a Stephanie E. Combs
4xx's: Alternate Name Forms (15)
5xx's: Related Names (5)
- 510 2 _ ‡a Klinik und Poliklinik für RadioOnkologie und Strahlentherapie ‡g München ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Klinik und Poliklinik für RadioOnkologie und Strahlentherapie
- 510 2 _ ‡a Klinikum Heidelberg
- 510 2 _ ‡a Klinikum Heidelberg ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a München ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
Works
Title | Sources |
---|---|
15 years of stereotactic radiotherapy at the Klinikum rechts der Isar | |
18F-FDG-PET/CT-Parameter als Prädiktoren für das Überleben und Therapieansprechen auf die neoadjuvante Radiochemotherapie bei Plattenepithelkarzinomen des Ösophagus | |
18F-FDG-PET/CT parameters as predictors of survival and response to neoadjuvant chemoradiation in esophageal squamous cell carcinoma | |
Advances in radiation therapy, 2018: | |
ALDH1A1 knockdown increases radiosensitivity and reduces migration in glioblastoma cells | |
Analyse der Anwendung einer Hochpräzisionsradiotherapie bei Patienten mit Leber- und Nebennierenmetastasen hinsichtlich Toxizität und Überleben | |
Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models | |
Analysis of two positioning systems in brain tumor irradiation with subsequent simulation and evaluation of effects of rotational errors in target volumes and organs at risk | |
Analysis of using high-precision radiotherapy in patients with liver- and adrenal metastases regarding toxicity and survival | |
Auswertung zweier Positionierungssysteme in der Hirntumorbestrahlung mit anschließender Simulation und Effektbewertung von Rotationsfehlern in Zielvolumen und Risikoorganen | |
Combining 68Ga-PSMA-PET/CT-directed and elective radiation therapy improves outcome in oligorecurrent prostate cancer: a retrospective multicenter study | |
Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) | |
Continued versus interrupted targeted therapy during metastasis-directed stereotactic radiotherapy: a retrospective multi-center safety and efficacy analysis | |
Data-based radiation oncology : design of clinical trials | |
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment | |
Development and Evaluation of MR-Based Radiogenomic Models to Differentiate Atypical Lipomatous Tumors from Lipomas | |
Effekt der Strahlendosis am zentralen gustatorischen System auf die Blutzuckerregulation : eine retrospektive Analyse bei Glioblastom-Patienten | |
Einfluss der PSMA-PET-Bildgebung für die Strahlentherapieplanung beim Prostatakarzinom | |
Ergebnisse nach Neutronentherapie eines an der Forschungsneutronenquelle Heinz Maier-Leibnitz (FRM II) bestrahlten Patientenkollektivs | |
Establishment of a 3D model to characterize the radioresponse of patient-derived glioblastoma cells | |
ESTRO ACROP guideline for target volume delineation of skull base tumors | |
Expert consensus on re-irradiation for recurrent glioma | |
Extrakranielle, stereotaktische Strahlentherapie am Klinikum rechts der Isar - Überlebensanalysen und Patient-reported Outcome | |
Factors associated with the decline of psychological support in hospitalized patients with cancer | |
First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments | |
HOX-Gene in der Pathogenese des Ewing-Sarkoms | |
Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma | |
Impact of Radiation Dose to the Central Gustatory System on Blood Glucose Regulation | |
Influence of the dose applied to the cochlea during radiotherapy of the vestibular schwannoma and its effect on hearing preservation | |
Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma | |
Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection | |
Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects | |
Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines | |
Modifikation der Strahlensensibilität von humanen Pankreaskarzinomzelllinien durch die phytotherapeutische Begleitbehandlung mit Curcumin | |
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study | |
A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT | |
Opportunities and alternatives of modern radiation oncology and surgery for the management of resectable brain metastases | |
Optimization of carbon ion and proton treatment plans using the raster-scanning technique for patients with unresectable pancreatic cancer | |
Outcome und Toxizität der TomoTherapie bei kindlichen Tumorerkrankungen | |
Patienten mit Analkarzinom und definitiver Radiochemotherapie von 2004-2018 am Klinikum Rechts der Isar: eine retrospektive Analyse | |
Personalisierte Radioonkologie des Pankreaskarzinoms | |
Prädiktion des Ansprechens einer palliativen Strahlentherapie von schmerzhaften Wirbelsäulenmetastasen | |
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score | |
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy | |
RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: a randomized multicenter phase II trial | |
Re-irradiation in the treatment of patients with cerebral metastases of solid tumors: retrospective analysis | |
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK) | |
Reduction of lung dose for stereotactic treatment of lung tumors using respiratory gating | |
Reduktion der Lungendosis bei stereotaktischer Bestrahlung von Lungentumoren durch Atemgating | |
Relevanz der MRT-Bildgebung während der Strahlentherapie in Bezug auf Tumorgeometrie und Veränderungen von Risikoorganen bei Patienten mit Kopf-Hals-Tumoren | |
Response prediction of palliative radiotherapy to painful spinal bone metastases | |
Results after neutron therapy of a patient collective radiated at the research neutron source Heinz Maier-Leibnitz (FRM II) | |
[TGF-Beta-s], PACAP und die Entwicklung der sympathoadrenalen Zelllinie | |
Tomotherapy of pediatric tumors: Outcome and toxicity rates | |
Untersuchung der Strahlendosis an der Cochlea bei Patienten mit Vestibularis-Schwannom nach Radiotherapie, sowie die Auswirkung auf die Hörminderung | |
Vergleich von Risikoscores für die Re-Bestrahlung maligner Rezidiv-Gliome | |
Zytogenetische Biodosimetrie zur Diagnostik des Strahlenschadens Optimierung und Entwicklung neuer Ansätze |